Diabetic cardiomyopathy and metabolic remodeling of the heart

Pavan K Battiprolu1, Camila Lopez-Crisosto, Zhao V Wang

  • 1Department of Internal Medicine (Cardiology), University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.

Life Sciences
|November 6, 2012
PubMed

Insights

Diabetic cardiomyopathy harms the heart independently of other conditions. Understanding its unique metabolic pathways offers new therapeutic targets for heart disease in diabetes patients.

Area of Science:

  • Cardiology
  • Metabolic Diseases
  • Pathophysiology

Background:

  • Diabetes mellitus incidence and prevalence are rising globally.
  • Diabetes significantly increases heart disease risk, often due to atherosclerosis and hypertension.
  • Diabetic cardiomyopathy is a distinct cardiac condition developing independently of other risk factors.

Purpose of the Study:

  • To review recent insights into the pathogenesis of diabetic cardiomyopathy.
  • To explore metabolic remodeling associated with diabetic heart disease.
  • To identify novel therapeutic targets for diabetes-specific heart disease.

Main Methods:

  • Review of recent scientific literature.
  • Analysis of studies on diabetic cardiomyopathy pathogenesis.
  • Investigation of metabolic remodeling in diabetic hearts.

Main Results:

  • Diabetic milieu directly impacts heart physiology, structure, and function.
  • Diabetic cardiomyopathy involves unique pathogenic mechanisms.
  • Current therapies focus on glucose control and late-stage heart failure management.

Conclusions:

  • Diabetic cardiomyopathy presents unique challenges requiring diabetes-specific interventions.
  • Understanding novel pathogenic pathways is crucial for developing targeted therapies.
  • Future research should focus on identifying and validating new therapeutic targets.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...